Base‐Resolution Analysis of Cisplatin–DNA Adducts at the Genome Scale
- 13 October 2016
- journal article
- research article
- Published by Wiley in Angewandte Chemie
- Vol. 128 (46) , 14458-14461
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Platinum Antitumor Complexes: 50 Years Since Barnett Rosenberg's DiscoveryJournal of Clinical Oncology, 2015
- Binding of Kinetically Inert Metal Ions to RNA: The Case of Platinum(II)2011
- Direct Cellular Responses to Platinum-Induced DNA DamageChemical Reviews, 2007
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005
- Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug ResistanceChemical Reviews, 2003
- Structure, Recognition, and Processing of Cisplatin−DNA AdductsChemical Reviews, 1999
- Repair of Cisplatin−DNA Adducts by the Mammalian Excision NucleaseBiochemistry, 1996
- HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease.Proceedings of the National Academy of Sciences, 1994
- Reevaluation of interaction of cis-dichloro(ethylenediamine)platinum(II) with DNABiochemistry, 1986
- Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitationBiochemistry, 1985